Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity

This study will test a study drug called REGN20934 to see how safe and well tolerated this drug is, as well as how the drug is processed in the body for participants with overweight or obesity. The study is looking at: * What side effects REGN20934 might cause * How much REGN20934 is in the blood at different times * If the body makes antibodies to REGN20934

NCT Number	NCT07594093
Lead Sponsor	Regeneron Pharmaceuticals
Conditions	Overweight or Obesity
Enrollment	90 participants
Start Date	2026-06-29
Primary Completion	2027-02-22 (estimated)
Study Completion	2027-02-22 (estimated)
Updated on ClinicalTrials.gov	2026-07-07